Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-301-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 8 March 2016 to 27 April 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- ethyl (2S)-2-{[ethenylbis({[(2S)-1-ethoxy-1-oxopropan-2-yl]oxy})silyl]oxy}propanoate
- EC Number:
- 701-301-6
- Molecular formula:
- C17H30O9Si
- IUPAC Name:
- ethyl (2S)-2-{[ethenylbis({[(2S)-1-ethoxy-1-oxopropan-2-yl]oxy})silyl]oxy}propanoate
- Test material form:
- liquid
- Details on test material:
- - Stabilisation: in water undergoes hydrolysis
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Purity: 92%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature, humidity should be avoid.
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Experimental Medicine Centre at the Medical University in Białystok
- Age at study initiation: 11 - 12 week old.
- Weight at study initiation: For the preliminary study 236-245 g. For the main study an average body weight of 231 g.
- Fasting period before study: 19h
- Housing:plastic cages covered with wire bar lids. The dimensions of the cages were 58 x 37 x 21 cm (length x width x height). In the preliminary experiment, the animals were caged individually. In the main experiment, there were four animals in one cage.UV-sterilized wood shavings were used as bedding
- Diet: ad libitum
- Water: ad libitum
- Acclimation period:The animals were quarantined and observed daily for 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 – 25 °C
- Humidity (%): 30 – 51%
- Air changes (per hr): about 16 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES:
Preliminary experiment: The animal treated with 300 mg/kg bw from 30.03.2016 to 13.04.2016. The animal treated with 2000 mg/kg bw from 05.04.2016 to 19.04.2016.
Main experiment: From 08.04.2016 to 22.04.2016.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:
For the preliminary experiment - 60 mg test item/1 ml oil suspension in one animal and 400 mg/1 ml oil suspension in a second animal.
For the main experiment: 400 mg/1 ml oil suspension
- Amount of vehicle (if gavage): 0.5 mL/100 g b.w. in the preliminary and main experiment
- Justification for choice of vehicle: Due to the low water solubility of the test item. - Doses:
- Preliminary experiment: 300 mg/kg b.w.and 2000 mg/kg b.w.
Main experiment: 2000 mg/kg b.w. - No. of animals per sex per dose:
- Preliminary experiment: 1 animal per sex per dose
Main experiment: 4 animals per sex per dose
The animal from the preliminary experiment which had received the dose of 2000 mg/kg b.w. was included in the main experiment. - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The observation of all animals for morbidity and mortality was conducted twice a day or once a day (on days off) during the 14-day experiment. Body weights of the animals were determined on days 0, 7, and 14.
- Necropsy of survivors performed: yes
- Other examinations performed:
Clinical signs: evaluation of general condition of the animals and detailed clinical observations (locomotor system, behaviour, reactions to stimuli, skin and hair, eyes and eyelides, respiratory system, urinary system, digestive system, reproductive system).
Gross examinations: observation of the external body surface, all natural apertures, and the cranial, thoracic, and abdominal cavities with their content. - Statistics:
- Not performed
Results and discussion
- Preliminary study:
- No signs of toxicity were stated on animals treated with 300 mg/kg b.w.and 2000 mg/kg b.w. Both animals survived the experiment. Body weight gain was observed in both animals but gross examinations did not reveal any pathological changes. According to these results, in the main experiment was administered a dose of 2000 mg/kg b.w.
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- The animals survived the experiment.
- Clinical signs:
- other: No signs of toxicity were stated.
- Gross pathology:
- Gross examinations did not reveal any pathological changes in the examined animals.
Any other information on results incl. tables
Body weights of the animals (g) – overall list.
Dose (mg/kg b.w.) |
Animal number |
Day of the experiment/ Body weight (g) |
Body weight gain(g) (From 0 to 14) |
||
0 |
7 |
14 |
|||
300 |
1* |
236 |
261 |
264 |
28 |
2000 |
1* |
245 |
266 |
269 |
24 |
2000 |
2 |
231 |
253 |
253 |
22 |
2000 |
3 |
227 |
252 |
247 |
20 |
2000 |
4 |
238 |
265 |
259 |
21 |
2000 |
5 |
228 |
259 |
264 |
36 |
* the female from the preliminary experiment.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The median lethal dose (LD50) of the test item on female rats is greater than 2000 mg/kg b.w.
- Executive summary:
The acute oral toxicity of the test item was determined on female Wistar rats in accordance to the OECD Guideline 420 with GLP. A preliminary experiment was conducted in which the test item at a single dose of 300 mg/kg b.w. was administered to one animal. Since no evident toxicity was observed in dose 300 mg/kg b.w., the test item at a single dose of 2000 mg/kg b.w. was administered to the second animal. No signs of toxicity or mortality were observed on both animals. On the grounds of the preliminary experiment results, four animals used in the main experiment were given the test item at a dose of 2000 mg/kg b.w. The test item in the form of an oil suspension in a volume of 0.5 mL/100 g b.w. was administered with a metal stomach tube. After the administration of the test item, the animals were observed for 14 days. General and detailed clinical observations were conducted daily during the entire experiment and body weights of the animals were determined on day 0, 7 and 14. During the 14-day experiment body weights of all animals increased. No signs of toxicity were stated and the animals survived the experiment. Gross examinations did not reveal any pathological changes in the examined animals. On the grounds of the study results LD50 of the test item is greater than 2000 mg/kg b.w.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.